PubMed

Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.

Lyss AP, Lilenbaum RC.

Clin Lung Cancer. 2009 Nov;10(6):410-3.PMID: 19900858 [PubMed - in process]Related articles

Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.

Ambrosone CB, Barlow WE, Reynolds W, Livingston RB, Yeh IT, Choi JY, Davis W, Rae JM, Tang L, Hutchins LR, Ravdin PM, Martino S, Osborne CK, Lyss AP, Hayes DF, Albain KS.

J Clin Oncol. 2009 Oct 20;27(30):4973-9. Epub 2009 Sep 14.PMID: 19752340 [PubMed - in process]Related articles

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

Choi JY, Barlow WE, Albain KS, Hong CC, Blanco JG, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff MD, Hayes DF, Ambrosone CB.

Clin Cancer Res. 2009 Aug 15;15(16):5258-66. Epub 2009 Aug 11.PMID: 19671875 [PubMed - in process]Related articles

Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

Fidias PM, Dakhil SR, Lyss AP, Loesch DM, Waterhouse DM, Bromund JL, Chen R, Hristova-Kazmierski M, Treat J, Obasaju CK, Marciniak M, Gill J, Schiller JH.

J Clin Oncol. 2009 Feb 1;27(4):591-8. Epub 2008 Dec 15.PMID: 19075278 [PubMed - indexed for MEDLINE]Related articles

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.

Hutchins LF, Green SJ, Ravdin PM, Lew D, Martino S, Abeloff M, Lyss AP, Allred C, Rivkin SE, Osborne CK.

J Clin Oncol. 2005 Nov 20;23(33):8313-21.PMID: 16293862 [PubMed - indexed for MEDLINE]Related articles

Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

Akerley W, Herndon JE Jr, Lyss AP, Choy H, Turrisi A, Graziano S, Williams T, Zhang C, Vokes EE, Green MR.

Clin Lung Cancer. 2005 Jul;7(1):47-53.PMID: 16098244 [PubMed - indexed for MEDLINE]Related articles

Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.

Malhotra V, Dorr VJ, Lyss AP, Anderson CM, Westgate S, Reynolds M, Barrett B, Perry MC.

Clin Breast Cancer. 2004 Dec;5(5):377-84.PMID: 15585077 [PubMed - indexed for MEDLINE]Related articles

70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.

Bogart JA, Herndon JE 2nd, Lyss AP, Watson D, Miller AA, Lee ME, Turrisi AT, Green MR; Cancer and Leukemia Group B study 39808.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):460-8.PMID: 15145163 [PubMed - indexed for MEDLINE]Related articles

Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

Lyss AP, Herndon JE 2nd, Lynch TJ Jr, Turrisi AT, Watson DM, Grethlein SJ, Green MR.

Clin Lung Cancer. 2002 Feb;3(3):205-10; discussion 211-2.PMID: 14662044 [PubMed]Related articlesFree article

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR.

Cancer. 2003 May 15;97(10):2480-6.PMID: 12733147 [PubMed - indexed for MEDLINE]Related articlesFree article

Strategies for limiting the side effects of cancer pain therapy.

Lyss AP, Portenoy RK.

Semin Oncol. 1997 Oct;24(5 Suppl 16):S16-28-34. Review. No abstract available. PMID: 9381225 [PubMed - indexed for MEDLINE]Related articles

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP.

Clin Cancer Res. 1995 Jul;1(7):699-704.PMID: 9816035 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

Kornblith AB, Hollis DR, Zuckerman E, Lyss AP, Canellos GP, Cooper MR, Herndon JE 2nd, Phillips CA, Abrams J, Aisner J, et al.

J Clin Oncol. 1993 Nov;11(11):2081-9.PMID: 8229122 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.

Canfield VA, Lyss AP.

Invest New Drugs. 1993 Nov;11(4):335-6. No abstract available. PMID: 8157476 [PubMed - indexed for MEDLINE]Related articles

Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity.

Lyss AP, Lilenbaum RC, Harris BE, Diasio RB.

Cancer Invest. 1993;11(2):239-40. No abstract available. PMID: 8462026 [PubMed - indexed for MEDLINE]Related articles

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.

Vokes EE, Lyss AP, Herndon JE 2nd, Cooper B, Perry MC, Vinciguerra V, Mason-Coughlin K, Green MR.

Ann Oncol. 1992 Nov;3(9):727-32.PMID: 1333267 [PubMed - indexed for MEDLINE]Related articles

Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B.

Lyss AP, Perry MC, Goutsou M, Propert K, Herndon JE 2nd, Mason-Coughlin K, Green MR.

Am J Clin Oncol. 1992 Oct;15(5):399-404.PMID: 1326224 [PubMed - indexed for MEDLINE]Related articles

Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experience.

Green MR, Kreisman H, Doll DC, Lyss AP, Clamon GH, Goutsou M, Perry MC, Propert KJ.

Semin Oncol. 1992 Feb;19(1 Suppl 2):44-9. Review.PMID: 1329222 [PubMed - indexed for MEDLINE]Related articles

A simple method to estimate the initial dose of gentamicin.

Lackner TE, Lyss AP.

Pharmacotherapy. 1992;12(3):195-200.PMID: 1608852 [PubMed - indexed for MEDLINE]Related articles

Evaluation of an implantable venous access system in a general oncology population.

Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP.

Oncology. 1992;49(6):474-8.PMID: 1465287 [PubMed - indexed for MEDLINE]Related articles

Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA, Welch MJ.

J Nucl Med. 1991 Aug;32(8):1526-31.PMID: 1869973 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of soft tissue sarcomas of the extremities.

Kraybill WG, Emami B, Lyss AP.

Surgery. 1991 Mar;109(3 Pt 1):233-5. Review.PMID: 2000553 [PubMed - indexed for MEDLINE]Related articles

Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial.

Lyss AP, Luedke SL, Einhorn L, Luedke DW, Raney M.

Oncology. 1989;46(6):357-9.PMID: 2511534 [PubMed - indexed for MEDLINE]Related articles

Metastatic thyroid adenocarcinoma presenting as exophthalmos.

Umbreit JN, Lyss AP.

Mo Med. 1988 Dec;85(12):792-4. No abstract available. PMID: 3237204 [PubMed - indexed for MEDLINE]Related articles

Appendiceal malignancies.

Lyss AP.

Semin Oncol. 1988 Apr;15(2):129-37. Review.PMID: 3285476 [PubMed - indexed for MEDLINE]Related articles

Systemic treatment for prostate cancer.

Lyss AP.

Am J Med. 1987 Dec;83(6):1120-8. Review.PMID: 3332569 [PubMed - indexed for MEDLINE]Related articles

Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases.

Saini J, Rich MW, Lyss AP.

Ann Intern Med. 1987 Jun;106(6):814-6.PMID: 3579067 [PubMed - indexed for MEDLINE]Related articles

Sweet's syndrome in association with solid tumors.

Grigsby PW, Umbreit JN, Lyss AP.

Am J Med. 1987 May;82(5):1084-5. No abstract available. PMID: 3578349 [PubMed - indexed for MEDLINE]Related articles

Treatment of disseminated non-small cell lung cancer. Guidelines for the practicing physician.

Lyss AP.

Postgrad Med. 1986 Nov 1;80(6):119-27. Review. No abstract available. PMID: 3022267 [PubMed - indexed for MEDLINE]Related articles

Ph1-positive acute leukemia with a 17q;21q translocation.

Nowell PC, Wilmoth D, Hoxie J, Lyss AP.

Cancer Genet Cytogenet. 1984 May;12(1):51-5.PMID: 6713358 [PubMed - indexed for MEDLINE]Related articles

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ.

J Clin Invest. 1984 Mar;73(3):611-25.PMID: 6368583 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemotherapy of advanced breast cancer. A general survey.

Lyss AP, Loeb V Jr.

Cancer. 1984 Feb 1;53(3 Suppl):778-82.PMID: 6546358 [PubMed - indexed for MEDLINE]Related articles

Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells.

Cines DB, Lyss AP, Bina M, Corkey R, Kefalides NA, Friedman HM.

J Clin Invest. 1982 Jan;69(1):123-8.PMID: 7054233 [PubMed - indexed for MEDLINE]Related articlesFree article

Adenocarcinoid tumor of the colon arising in preexisting ulcerative colitis.

Lyss AP, Thompson JJ, Glick JH.

Cancer. 1981 Aug 1;48(3):833-9.PMID: 7248910 [PubMed - indexed for MEDLINE]Related articles